Last quarter (Q ), Aslan Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Aslan Pharmaceuticals's net income was $―. See Aslan Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	$ 12.00M	$ -51.38M	$ -31.59M	-	$ -44.07M
Cost of Revenue	-	-	-	-	-	$ -407.26K
Gross Profit	-	$ 12.00M	$ -51.38M	$ -31.59M	-	$ -44.48M
Operating Expense	$ 22.47M	$ 55.75M	$ 47.91M	$ 32.74M	$ -17.86M	$ -25.43M
Operating Income	$ -22.47M	$ -43.75M	$ -99.29M	$ -64.33M	$ -17.86M	$ -69.90M
Net Non Operating Interest Income Expense	$ -1.69M	$ -3.93M	$ 354.46K	$ -1.86M	$ -772.81K	$ 150.61K
Other Income Expense	$ 210.40K	$ -3.92M	$ 51.43M	$ -3.01M	$ -31.76M	$ -70.09M
Pretax Income	$ -23.94M	$ -44.09M	$ -150.37M	$ -94.50M	$ -50.39M	$ -140.74M
Tax Provision	$ 19.84K	$ 132.67K	$ 99.22K	-	-	$ -408.00K
Earnings From Equity Interest Net Of Tax	-	$ -8.59K	$ -436.03K	$ -405.71K	-	-
Net Income Common Stockholders	$ -23.96M	$ -44.22M	$ -154.15M	$ -94.77M	$ -51.16M	$ -141.20M
Basic EPS	$ -1.50	$ -0.11	-	-	-	$ -7.25
Diluted EPS	$ -1.50	$ -0.11	-	-	-	-
Basic Average Shares	$ 27.90M	$ 411.24M	-	-	-	$ 6.50M
Diluted Average Shares	$ 27.90M	$ 411.24M	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 22.47M	$ 55.75M	$ 47.91M	$ 32.74M	$ -17.86M	$ -25.83M
Net Income From Continuing And Discontinued Operation	$ -23.96M	$ -44.22M	$ -154.15M	$ -94.77M	$ -51.16M	$ -141.20M
Normalized Income	$ -23.96M	$ -32.40M	-	-	-	-
Interest Expense	$ 1.81M	-	-	-	-	-
EBIT	$ -22.13M	$ -39.76M	$ -150.90M	$ -92.64M	$ -49.62M	$ -140.90M
EBITDA	$ -22.13M	$ -39.41M	$ -150.57M	$ -92.36M	-	-

Currency in USD

Aslan Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing